EAM Investors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

EAM Investors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,795	Closed	-$2.15M	–	434
2020 Q3	$2.15M	Sell	15,795 -363	-2%	-$38.6K	0.51%	51
2020 Q2	$1.56M	Sell	16,158 -2,081	-11%	-$174K	0.35%	144
2020 Q1	$855K	Sell	18,239 -1,946	-10%	-$125K	0.27%	162
2019 Q4	$1.47M	Buy	+20,185	New	+$1.22M	0.32%	149
2018 Q2	–	Sell	-66,803	Closed	-$3.26M	–	390
2018 Q1	$3.26M	Buy	66,803 +46,392	+227%	+$2.41M	0.54%	58
2017 Q4	$859K	Sell	20,411 -77,979	-79%	-$3M	0.15%	225
2017 Q3	$4.22M	Buy	+98,390	New	+$3.14M	0.56%	46
2016 Q4	–	Sell	-45,794	Closed	-$748K	–	398
2016 Q3	$748K	Buy	+45,794	New	+$827K	0.1%	281

EAM Investors's MYOK Position: Q4 2020 in Review

EAM Investors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 15,795 shares — an estimated $2.15M sold.

EAM Investors first reported a position in MYOK in Q3 2016 and held it in 8 quarters. The position peaked at $4.22M in Q3 2017. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

EAM Investors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
EAM Investors sold 15,795 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.15M.
EAM Investors first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
EAM Investors's MyoKardia, Inc. Common Stock position peaked at $4.22M in Q3 2017.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.